In this episode of Invisible Ink, molecular biologist and biotech entrepreneur Daisy Robinton, founder of Oviva Therapeutics, joins Shubha Chakravarthy to share her journey from academia to leading a women’s health startup.
Daisy turned a personal encounter with gaps in female physiology knowledge—despite holding a PhD— into her mission to address ovarian function as a key driver of women’s healthspan, all the way to a successful exit in a tough funding and M&A environment.
Check out this episode for her thoughtful and pragmatic insights on:
- How to transition successfully from a scientist to founder
- How to tell if your biotech asset is ready for commercialization
- How to balance science and business as a scientist-founder
- The challenges of fundraising in biotech and how to set yourself up for success
- The art of making science-business tradeoffs, and how to do it well
- How to convince skeptical male investors of the market opportunity in women's health
- Tested tips from the trenches for first time CEO's
- Why storytelling is a game changer, and how to do it well for any audience
- Thinking ahead: exit and post-exit realities
- Tips to leverage your scientific training to translate into any domain
and much more!
